Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J. A. Thomis"'
Autor:
J. A. Thomis
Publikováno v:
Cardiovascular Drugs and Therapy. 4:585-594
The safety of encainide has been evaluated using retrospective analyses of the Bristol-Myers Supraventricular and Ventricular Arrhythmias data base and of the Post-Marketing Adverse Experience Report data and prospective analyses of the Cardiac Arrhy
Publikováno v:
European Journal of Clinical Pharmacology. 21:87-92
28 patients, aged 35-62 years, with uncomplicated hypertension, entered a double-blind, crossover study, in which the effects of single daily doses of sotalol and metoprolol were compared. Both drugs exerted a clinically useful anti-hypertensive effe
Autor:
J. A. Thomis, H. H. Soep, J. P. Fillastre, D. S. Reeves, R Daneels, T. Hallynck, J Boelaert, Ethan Rubinstein
Publikováno v:
Journal of Antimicrobial Chemotherapy. 6:286-288
Publikováno v:
International journal of clinical pharmacology, therapy, and toxicology. 20(2)
The long-term electrocardiographic effects of sotalol, a beta blocker tha prolongs the cardiac repolarization time in animals, were investigated in ten hypertensive patients and compared to ten matched hypertensive patients treated with diuretics. An
Publikováno v:
European journal of clinical pharmacology. 21(6)
The efficacy of chronic oral treatment with a total daily dose of 320 mg sotalol, given as a single or as two divided doses, was compared with placebo in a double-blind cross-over study of 12 patients with angina pectoris. Sotalol given once or twice
Publikováno v:
European journal of clinical pharmacology. 18(4)
Ten hypertensive patients with modern to severe impairment of renal function were treated with sotalol for 5 to 10 weeks (average 6.4 weeks). Dosage was individually titrated (range 80 to 480 mg daily). The drug was given once daily in the morning. I